| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director | C/O ALUMIS INC., 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO | /s/ Srinivas Akkaraju | 13 Jan 2026 | 0001253170 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALMS | Common Stock | Purchase | $9,999,995 | +588,235 | +46% | $17.00 | 1,853,488 | 09 Jan 2026 | By Samsara Opportunity Fund, L.P. | F1 |
| holding | ALMS | Common Stock | 4,491,731 | 09 Jan 2026 | By Samsara BioCapital, L.P. | F2 |
| Id | Content |
|---|---|
| F1 | Shares are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the shares held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the shares held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. |
| F2 | Shares are directly held by Samsara BioCapital LP. ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. |